These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18949431)

  • 1. The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas.
    Kimura K; Toyooka S; Tsukuda K; Yamamoto H; Suehisa H; Soh J; Otani H; Kubo T; Aoe K; Fujimoto N; Kishimoto T; Sano Y; Pass HI; Date H
    Oncol Rep; 2008 Nov; 20(5):1265-8. PubMed ID: 18949431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.
    Dai Z; Popkie AP; Zhu WG; Timmers CD; Raval A; Tannehill-Gregg S; Morrison CD; Auer H; Kratzke RA; Niehans G; Amatschek S; Sommergruber W; Leone GW; Rosol T; Otterson GA; Plass C
    Oncogene; 2004 Apr; 23(20):3521-9. PubMed ID: 15116090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation of the bone morphogenetic protein 6 gene in multiple myeloma.
    Hashida Y; Nemoto Y; Imajoh M; Murakami M; Taniguchi A; Komatsu N; Yokoyama A; Daibata M
    Oncol Rep; 2012 Mar; 27(3):825-30. PubMed ID: 22086350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.
    Kobatake T; Yano M; Toyooka S; Tsukuda K; Dote H; Kikuchi T; Toyota M; Ouchida M; Aoe M; Date H; Pass HI; Doihara H; Shimizu N
    Oncol Rep; 2004 Nov; 12(5):1087-92. PubMed ID: 15492797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer.
    Kraunz KS; Nelson HH; Liu M; Wiencke JK; Kelsey KT
    Br J Cancer; 2005 Oct; 93(8):949-52. PubMed ID: 16175182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
    Ogama Y; Ouchida M; Yoshino T; Ito S; Takimoto H; Shiote Y; Ishimaru F; Harada M; Tanimoto M; Shimizu K
    Int J Oncol; 2004 Sep; 25(3):685-91. PubMed ID: 15289870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma.
    Daibata M; Nemoto Y; Bandobashi K; Kotani N; Kuroda M; Tsuchiya M; Okuda H; Takakuwa T; Imai S; Shuin T; Taguchi H
    Clin Cancer Res; 2007 Jun; 13(12):3528-35. PubMed ID: 17575215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells.
    Toyooka S; Carbone M; Toyooka KO; Bocchetta M; Shivapurkar N; Minna JD; Gazdar AF
    Oncogene; 2002 Jun; 21(27):4340-4. PubMed ID: 12082623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma.
    Teramen H; Tsukuda K; Tanaka N; Ueno T; Kubo T; Ando M; Soh J; Asano H; Pass HI; Toyooka S; Miyoshi S
    Acta Med Okayama; 2011 Jun; 65(3):179-84. PubMed ID: 21709715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression.
    Lin J; Lai M; Huang Q; Ma Y; Cui J; Ruan W
    J Pathol; 2007 May; 212(1):83-90. PubMed ID: 17334979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
    Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
    Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
    Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
    Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.
    Kubo T; Toyooka S; Tsukuda K; Sakaguchi M; Fukazawa T; Soh J; Asano H; Ueno T; Muraoka T; Yamamoto H; Nasu Y; Kishimoto T; Pass HI; Matsui H; Huh NH; Miyoshi S
    Clin Cancer Res; 2011 Aug; 17(15):4965-74. PubMed ID: 21673066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.
    Destro A; Ceresoli GL; Baryshnikova E; Garassino I; Zucali PA; De Vincenzo F; Bianchi P; Morenghi E; Testori A; Alloisio M; Santoro A; Roncalli M
    Lung Cancer; 2008 Mar; 59(3):369-76. PubMed ID: 17920725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.